[HTML][HTML] Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study

L Abenavoli, M Greco, N Milic, F Accattato, D Foti… - Nutrients, 2017 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide,
characterized by liver fatty acid accumulation and fibrosis, not due to excessive alcohol …

[HTML][HTML] Effects of chromium picolinate supplementation on cardiometabolic biomarkers in patients with type 2 diabetes mellitus: A randomized clinical trial

AT Talab, H Abdollahzad, SM Nachvak… - Clinical nutrition …, 2020 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is a serious public health problem accompanies with
several complications. This study was conducted to evaluate the effects of chromium …

Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with …

S Asghari, M Asghari-Jafarabadi, MH Somi… - Journal of the …, 2018 - Taylor & Francis
Objective: There is a promising perspective regarding the potential effect of resveratrol in
preventing and treating metabolic disturbances similar to that of calorie restriction. The aim …

[HTML][HTML] Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver

E Aigner, G Weiss, C Datz - World journal of hepatology, 2015 - ncbi.nlm.nih.gov
Elevated iron stores as indicated by hyperferritinemia with normal or mildly elevated
transferrin saturation and mostly mild hepatic iron deposition are a characteristic finding in …

[HTML][HTML] Lycopene modulates pathophysiological processes of non-alcoholic fatty liver disease in obese rats

M Róvero Costa, J Leite Garcia… - Antioxidants, 2019 - mdpi.com
Background: The higher consumption of fat and sugar are associated with obesity
development and its related diseases such as non-alcoholic fatty liver disease (NAFLD) …

[HTML][HTML] Randomized clinical trial: bergamot citrus and wild cardoon reduce liver steatosis and body weight in non-diabetic individuals aged over 50 years

Y Ferro, T Montalcini, E Mazza, D Foti… - Frontiers in …, 2020 - frontiersin.org
Background: Non-alcoholic fatty liver disease is the most common cause of liver-related
morbidity and mortality in the world. However, no effective pharmacological treatment for this …

Therapeutic effects of resveratrol on nonalcoholic fatty liver disease through inflammatory, oxidative stress, metabolic, and epigenetic modifications

M Karimi, B Abiri, PC Guest, M Vafa - Physical Exercise and Natural and …, 2022 - Springer
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing around the world,
in association with the progressive elevation in overweight and obesity. The accumulation of …

Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover …

NC Li, C Cui, J Xu, MT Mi, J Wang, Y Qin - The American Journal of Clinical …, 2024 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) has become a growing public health
problem worldwide. However, there is still lack of effective treatment strategies except …

[HTML][HTML] Effects of the Mixture of Cichorium intybus L. and Cinnamomum zeylanicum on Hepatic Enzymes Activity and Biochemical Parameters in Patients with …

ZS Asl, AA Malekirad, M Abdollahi, A Bakhshipour… - Health, 2014 - scirp.org
The prevalence of nonalcoholic fatty liver disease (NAFLD) as a metabolic disorder affecting
the liver function is rapidly increasing and there is a need to develop new and more efficient …

The effect of melatonin on treatment of patients with non-alcoholic fatty liver disease: a randomized double blind clinical trial

M Bahrami, M Cheraghpour, S Jafarirad… - … therapies in medicine, 2020 - Elsevier
Objectives Many factors implicated in the pathogenesis of non-alcoholic fatty liver disease
(NAFLD) are including oxidative stress, insulin resistance and abnormal production of …